Literature DB >> 15240586

Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization.

N Binkley1, D Krueger, C S Cowgill, L Plum, E Lake, K E Hansen, H F DeLuca, M K Drezner.   

Abstract

Endemic hypovitaminosis D contributes to osteoporosis development. However, variation in 25-hydroxyvitamin D (25OHD) measurement is reported and confounds the diagnosis of vitamin D insufficiency/deficiency. This report emphasizes the marked variability observed in serum 25OHD measurements between laboratories.Initially, postmenopausal women had serum 25OHD determinations: 42 in laboratory A, 20 in laboratory B. Their mean (sem) serum 25OHD concentrations were 46 (2.1) and 21 (2.3) ng/ml in laboratories A and B, respectively. Furthermore, there was little overlap in serum 25OHD among these clinically similar individuals. Specifically, 17% of those measured in laboratory A but 90% in laboratory B were below an arbitrary threshold value of 32 ng/ml.Subsequently, serum was obtained from 10 healthy adults. Two aliquots from each individual, one of which was spiked with 20 ng/ml 25OHD, were sent to six laboratories. Substantial variability was noted between these six laboratories. The mean serum 25OHD concentration ranged from 17.1-35.6 ng/ml. Similarly, the mean increase produced by spiking with 20 ng/ml ranged from 7.7-18.0 ng/ml.In conclusion, 25OHD assays yield markedly differing results; whether an individual is found to have low or normal vitamin D status is a function of the laboratory used. If the medical community is to make progress in correcting widespread hypovitaminosis D, 25OHD measurement must be standardized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240586     DOI: 10.1210/jc.2003-031979

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  151 in total

1.  Development and certification of a standard reference material for vitamin D metabolites in human serum.

Authors:  Karen W Phinney; Mary Bedner; Susan S-C Tai; Veronica V Vamathevan; Lane C Sander; Katherine E Sharpless; Stephen A Wise; James H Yen; Rosemary L Schleicher; Madhulika Chaudhary-Webb; Christine M Pfeiffer; Joseph M Betz; Paul M Coates; Mary Frances Picciano
Journal:  Anal Chem       Date:  2011-12-28       Impact factor: 6.986

Review 2.  Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary).

Authors:  David A Hanley; Ann Cranney; Glenville Jones; Susan J Whiting; William D Leslie
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

Review 3.  Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.

Authors:  David A Hanley; Ann Cranney; Glenville Jones; Susan J Whiting; William D Leslie; David E C Cole; Stephanie A Atkinson; Robert G Josse; Sidney Feldman; Gregory A Kline; Cheryl Rosen
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

4.  The association of serum 25-hydroxyvitamin D with indicators of bone quality in men of Caucasian and African ancestry.

Authors:  K E Barbour; J M Zmuda; M J Horwitz; E S Strotmeyer; R Boudreau; R W Evans; K E Ensrud; C L Gordon; M A Petit; A L Patrick; J A Cauley
Journal:  Osteoporos Int       Date:  2010-11-23       Impact factor: 4.507

5.  NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary.

Authors:  Elizabeth A Yetley; Christine M Pfeiffer; Rosemary L Schleicher; Karen W Phinney; David A Lacher; Sylvia Christakos; John H Eckfeldt; James C Fleet; George Howard; Andrew N Hoofnagle; Siu L Hui; Gary L Lensmeyer; Joseph Massaro; Munro Peacock; Bernard Rosner; Donald Wiebe; Regan L Bailey; Paul M Coates; Anne C Looker; Christopher Sempos; Clifford L Johnson; Mary Frances Picciano
Journal:  J Nutr       Date:  2010-09-29       Impact factor: 4.798

6.  Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Jonathan F French; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-02-12       Impact factor: 2.745

7.  Vitamin D deficiency in older men.

Authors:  Eric Orwoll; Carrie M Nielson; Lynn M Marshall; Lori Lambert; Kathleen F Holton; Andrew R Hoffman; Elizabeth Barrett-Connor; James M Shikany; Tien Dam; Jane A Cauley
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

8.  Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women.

Authors:  P Gerdhem; K A M Ringsberg; K J Obrant; K Akesson
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

Review 9.  Not enough vitamin D: health consequences for Canadians.

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

10.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).

Authors:  B Littorin; P Blom; A Schölin; H J Arnqvist; G Blohmé; J Bolinder; A Ekbom-Schnell; J W Eriksson; S Gudbjörnsdottir; L Nyström; J Ostman; G Sundkvist
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.